CAPN1 and Parkinson disease: Increasing evidence has linked calpain-1 and calpain-2 to stroke, TBI, and AD [36,93,94,95,96,97], spinal cord injury [98], Parkinson’s disease (PD) [99], and global neurodegeneration [100].